Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Bio-Gene Technology Ltd. ( (AU:BGT) ) has issued an announcement.
Bio-Gene Technology Limited announced the issuance of 50,340,392 fully paid ordinary shares without disclosure to investors under specific provisions of the Corporations Act 2001. This move aligns with the company’s compliance with relevant legislative requirements and does not necessitate additional disclosures for investor assessment. The issuance is part of Bio-Gene’s strategic efforts to enhance its market position and operational capabilities in the bio-insecticide industry.
More about Bio-Gene Technology Ltd.
Bio-Gene Technology Limited is an Australian company specializing in the development of novel bio-insecticides aimed at addressing global challenges related to insecticide resistance and toxicity. The company’s products, based on naturally occurring compounds, are designed to effectively control pests while minimizing impact on human health and the environment. These products have diverse applications in public health, crop protection, grain storage, and consumer use, providing safe and effective pest management solutions.
Average Trading Volume: 184,781
Technical Sentiment Signal: Sell
Current Market Cap: A$4.63M
See more data about BGT stock on TipRanks’ Stock Analysis page.